For many years oral antiretroviral medications have been the only medications available for persons living with HIV. However, long-acting injectable antiretroviral medications are now available as an alternative for people who meet specific criteria. This lecture will review long-acting injectable ART.

By the end of this training, participants should be able to:

  1. Review available drug regimen options and recommendations for the initiation of HIV antiretroviral treatment (ART).
  2. Describe the treatment guidelines and recommendations for prescribing cabotegravir/rilpivirine as injectable (ART).
  3. Compare and contrast the benefits and potential pitfalls of prescribing injectable ART.